Literature DB >> 3493720

Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen.

T J Ferro, J A Kern, J A Elias, M Kamoun, R P Daniele, M D Rossman.   

Abstract

We compared the relative abilities of alveolar macrophages (AM), blood monocytes (BM), and density-fractionated AM to support antigen- and mitogen-induced proliferation of autologous T cells in normal volunteers. The AM were able to promote the T-cell proliferative response to antigen, but they did so less effectively than did the BM. Density-fractionated AM were heterogeneous in their ability to support T-cell responses. More proliferation occurred with the densest AM than with the least dense AM. In contrast to antigen-induced responses, mitogen-induced responses were supported more effectively by AM and density-fractionated AM than by BM. The ability of AM, density-fractionated AM, and BM to support T-cell responses did not correlate with surface expression of class II major histocompatibility determinants. Addition of purified IL-1 resulted in a partial restoration of T-cell proliferation when low-density AM were used but no augmentation when unfractionated AM were used. This suggests that reduced IL-1 activity may partially explain the decreased ability of low density AM to promote T-cell responses, but that other processes may also contribute to differences in accessory cell function among AM, BM, and density-fractionated AM.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493720     DOI: 10.1164/arrd.1987.135.3.682

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Reduction in HLA-DR antigen density on alveolar macrophages of smokers.

Authors:  W Pankow; K Neumann; J Rüschoff; R Schröder; P von Wichert
Journal:  Lung       Date:  1991       Impact factor: 2.584

2.  Normal and sarcoid alveolar macrophages differ in their ability to present antigen and to cluster with autologous lymphocytes.

Authors:  V A Gant; Z Shakoor; I L Barbosa; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

3.  Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages.

Authors:  A de Haan; G Groen; J Prop; N van Rooijen; J Wilschut
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 4.  Immune aspects of sarcoidosis.

Authors:  L W Poulter
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

5.  Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophages.

Authors:  J W Upham; D H Strickland; B W Robinson; P G Holt
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

6.  Four monoclonal antibodies, AMH-1, -2, -3, and -4, give varied reactivities with monocytes, alveolar macrophages, and epithelioid-cell granulomas.

Authors:  J Akiyama; K Chida; A Sato; A Yamashita
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

7.  Delineation of pulmonary alveolar macrophage subpopulations by flow cytometry in normal subjects and in patients with lung cancer.

Authors:  C F McDonald; P Hutchinson; R C Atkins
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

8.  Impaired protein catabolism in Trypanosoma cruzi-infected macrophages: possible involvement in antigen presentation.

Authors:  N Plasman; J G Guillet; B Vray
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

9.  Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion.

Authors:  J W Upham; D H Strickland; N Bilyk; B W Robinson; P G Holt
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

10.  The role of human alveolar macrophages in the allogeneic and autologous mixed leucocyte reactions.

Authors:  D B Ettensohn; P G Duncan; M J Jankowski
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.